Celcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.
Celcuity has raised $500.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in June 2026.
Celcuity's investors include RA Capital Management, Vivo Capital, New Enterprise Associates, Blue Owl, Oxford Finance LLC.
Celcuity is headquartered in Hamel, United States.
Celcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.
Celcuity is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Celcuity — Funding & Investors." VCBacked, June 3, 2026, https://www.vcbacked.co/company/celcuity. Accessed July 19, 2026.
VCBacked. (2026). Celcuity — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/celcuity
{{cite web |title=Celcuity — Funding & Investors |url=https://www.vcbacked.co/company/celcuity |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated